✦ LIBER ✦

Pharmacokinetic analysis of a combined chemoendocrine treatment with paclitaxel and toremifene for metastatic breast cancer

✍ Scribed by Toshiaki Saeki; Atsushi Okita; Kenjiro Aogi; Tomokazu Kakishita; Riki Okita; Naruto Taira; Yumi Ohama; Shigemitsu Takashima; Kiyohiro Nishikawa

Book ID: 107643703
Publisher: Springer Japan
Year: 2008
Tongue: English
Weight: 363 KB
Volume: 16
Category: Article
ISSN: 1340-6868
DOI: 10.1007/s12282-008-0075-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A cost-benefit analysis of bevacizumab i

A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer

✍ Alberto J. Montero; Kiran Avancha; Stefan Glück; Gilberto Lopes 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 177 KB

Successful treatment with weekly paclita

Successful treatment with weekly paclitaxel and carboplatin combined with trastuzumab in a patient with heavily pretreated metastatic breast cancer

✍ Yoshihiro Kikuchi; Masashi Takano; Kazuya Kudoh; Tsunekazu Kita; Kazuhiko Sato 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 489 KB

Pharmacokinetic and pharmacodynamic anal

Pharmacokinetic and pharmacodynamic analysis of combined chemotherapy with carboplatin and paclitaxel for patients with ovarian cancer

✍ A. Arakawa; H. Nishikawa; K. Suzumori; N. Kato 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 126 KB

nab-Paclitaxel for first-line treatment

nab-Paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis

✍ O’Shaughnessy, Joyce; Gradishar, William J.; Bhar, Paul; Iglesias, Jose 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 424 KB

Q-TWiST analysis of lapatinib combined w

Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer

✍ Sherrill, B; Amonkar, M M; Stein, S; Walker, M; Geyer, C; Cameron, D 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

Combination chemotherapy with paclitaxel

Combination chemotherapy with paclitaxel (T) and epirubicin (E) for metastatic breast cancer (MBC): A phase I–II study

✍ A. Durando; O. Alabiso; R. Bellino; F. Genta; D. Katsaros; A. Malossi; S. Aidala 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 324 KB